Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gh Research Plc (GHRS)

Gh Research Plc (GHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 619,653
  • Shares Outstanding, K 52,028
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,590 K
  • 60-Month Beta 0.86
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.89
Trade GHRS with:

Options Overview Details

View History
  • Implied Volatility 163.41% ( +8.05%)
  • Historical Volatility 81.36%
  • IV Percentile 91%
  • IV Rank 70.11%
  • IV High 214.13% on 11/22/23
  • IV Low 44.44% on 12/13/23
  • Put/Call Vol Ratio 0.67
  • Today's Volume 5
  • Volume Avg (30-Day) 9
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 772
  • Open Int (30-Day) 769

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.24
  • Number of Estimates 3
  • High Estimate -0.22
  • Low Estimate -0.27
  • Prior Year -0.15
  • Growth Rate Est. (year over year) -60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.18 +6.53%
on 06/26/24
14.99 -20.55%
on 06/05/24
-2.18 (-15.47%)
since 05/31/24
3-Month
10.30 +15.63%
on 04/25/24
14.99 -20.55%
on 06/05/24
+0.87 (+7.88%)
since 04/02/24
52-Week
5.05 +135.84%
on 12/18/23
14.99 -20.55%
on 06/05/24
+0.05 (+0.38%)
since 06/30/23

Most Recent Stories

More News
GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

DUBLIN, Ireland, May 18, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming...

GHRS : 11.91 (+1.36%)
GH Research Reports Full Year 2021 Financial Results and Provides Business Updates

DUBLIN, Ireland., March 28, 2022 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming...

GHRS : 11.91 (+1.36%)
Fighting Back Against the Mental Health Crisis with Outside-the-Box Thinking and Therapeutics

USA News Group – Before the global health crisis began at the beginning of 2020, 1 in 5 adults were receiving mental health treatment. As society emerges from the last two and a half years of disruptions,...

MOOD.CN : 0.1500 (-46.43%)
GHRS : 11.91 (+1.36%)
MNMD : 6.96 (-1.56%)
CYBN : 0.2649 (-0.04%)
JNJ : 146.03 (-0.28%)
Psychedelic Therapies Offer Hope for Mental Health

NetworkNewsWire Editorial Coverage : Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of the nervous system to change...

CYBN.NE : 0.3550 (-4.05%)
MMED.NE : 14.9000 (+9.48%)
CYBN : 0.2649 (-0.04%)
CMPS : 5.96 (+0.17%)
MNMD : 6.96 (-1.56%)
ATAI : 1.3000 (-3.70%)
GHRS : 11.91 (+1.36%)
Psychedelic Therapies Offer Hope for Mental Health

NetworkNewsWire Editorial Coverage   New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability...

CYBN.NE : 0.3550 (-4.05%)
MMED.NE : 14.9000 (+9.48%)
CYBN : 0.2649 (-0.04%)
CMPS : 5.96 (+0.17%)
MNMD : 6.96 (-1.56%)
ATAI : 1.3000 (-3.70%)
GHRS : 11.91 (+1.36%)
GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates

DUBLIN, Ireland, Dec. 06, 2021 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming...

GHRS : 11.91 (+1.36%)
GH Research PLC Provides Business Updates and Reports Second Quarter 2021 Financial Results

DUBLIN, Ireland, Sept. 23, 2021 (GLOBE NEWSWIRE) -- GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...

GHRS : 11.91 (+1.36%)

Business Summary

GH Research PLC is a clinical-stage biopharmaceutical company. It dedicated to treat psychiatric and neurological disorders. The company's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression. GH Research PLC is...

See More

Key Turning Points

3rd Resistance Point 12.27
2nd Resistance Point 12.12
1st Resistance Point 12.01
Last Price 11.91
1st Support Level 11.75
2nd Support Level 11.60
3rd Support Level 11.49

See More

52-Week High 14.99
Last Price 11.91
Fibonacci 61.8% 11.19
Fibonacci 50% 10.02
Fibonacci 38.2% 8.85
52-Week Low 5.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar